IOVANCE BIOTHERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

IOVANCE BIOTHERAPEUTICS, INC. reported Common Stock Shares Outstanding of 411.94 million shares for the year ending 2025.

  • IOVANCE BIOTHERAPEUTICS, INC. showed an increase of +35.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from IOVANCE BIOTHERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), IOVANCE BIOTHERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 459.4%.
  • Historical annual values: Fiscal year 2025: 411.94 million shares | Fiscal year 2024: 305.25 million shares | Fiscal year 2023: 256.14 million shares | Fiscal year 2022: 187.81 million shares | Fiscal year 2021: 157.00 million shares | Fiscal year 2020: 147.87 million shares | Fiscal year 2019: 126.41 million shares | Fiscal year 2018: 123.42 million shares | Fiscal year 2017: 73.16 million shares | Fiscal year 2016: 62.25 million shares | Fiscal year 2015: 48.55 million shares | Fiscal year 2014: 33.75 million shares | Fiscal year 2013: 20.02 million shares | Fiscal year 2012: 818,806 shares | Fiscal year 2011: 77.99 million shares | Fiscal year 2010: 73.64 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: